Disease progression in multiple sclerosis: Combining physicians' and patients' perspectives?

Multiple Sclerosis Journal

Volumn 17, Issue 2, 2011, Pages 234-240

  Kragt, J J ^a   Nielsen, J M ^a   Van Der Linden, F A H ^a   Polman, C H ^a   Uitdehaag, B M J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Clinical neurology; Expanded Disability Status Scale; multiple sclerosis; Multiple Sclerosis Functional Composite; Multiple Sclerosis Impact Scale; scales

Indexed keywords

ADULT; ARTICLE; DISEASE COURSE; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS IMPACT SCALE; NEUROLOGIC EXAMINATION; NINE HOLE PEG TEST; PHYSICIAN; PROGNOSIS; RATING SCALE; SCORING SYSTEM; TIMED 25 FOOT WALK;

EID: 79951532611     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458510385505     Document Type: Article

References (27)

1. Kurtzke JF Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology 1983 ; 33: 1444-1452. (Pubitemid 14237132)
2. Hobart J., Freeman J. and Thompson A. Kurtzke scales revisited: the application of psychometric methods to clinical intuition. Brain 2000 ; 123: 1027-1040. (Pubitemid 30224198)
3. Cutter GR, Baier ML, Rudick RA, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999 ; 122: 871-882. (Pubitemid 29219261)
4. Cohen JA, Cutter GR, Fischer JS, et al. Benefit of interferon beta-1a on MSFC progression in secondary progressive MS. Neurology 2002 ; 59: 679-687.
5. Polman CH, O'Connor PW, Havrdova E., et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2006 ; 354: 899-910.
6. Rudick RA, Stuart WH, Calabresi PA, et al. Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N Engl J Med 2006 ; 354: 911-923.
7. Hoogervorst EL, Kalkers NF, Cutter GR, Uitdehaag BM and Polman CH The patient's perception of a (reliable) change in the Multiple Sclerosis Functional Composite. Mult Scler 2004 ; 10: 55-60. (Pubitemid 38100527)
8. Kragt JJ, van der Linden FA, Nielsen JM, Uitdehaag BM and Polman CH Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis. Mult Scler 2006 ; 12: 594-598. (Pubitemid 46940633)
9. Schwid SR, Goodman AD, McDermott MP, Bever CF and Cook SD Quantitative functional measures in MS: what is a reliable change? Neurology 2002 ; 58: 1294-1296. (Pubitemid 34411881)
10. Bosma L., Kragt J., Brieva L., et al. The search for responsive clinical endpoints in primary progressive multiple sclerosis. Mult Scler 2009 ; 15: 715-720.
11. Rudick RA, Polman CH, Cohen JA, et al. Assessing disability progression with the Multiple Sclerosis Functional Composite. Mult Scler 2009 ; 15: 984-997.
12. Hobart J., Lamping D., Fitzpatrick R., Riazi A. and Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 2001 ; 124: 962-973. (Pubitemid 32458508)
13. Hoogervorst EL, van Winsen LM, Eikelenboom MJ, Kalkers NF, Uitdehaag BM and Polman CH Comparisons of patient self-report, neurologic examination, and functional impairment in MS. Neurology 2001 ; 56: 934-937. (Pubitemid 32290811)
14. Kalkers NF, de Groot V., Lazeron RH, et al. MS functional composite: relation to disease phenotype and disability strata. Neurology 2000 ; 54: 1233-1239. (Pubitemid 30174039)
15. Hoogervorst EL, Zwemmer JN, Jelles B., Polman CH and Uitdehaag BM Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability. Mult Scler 2004 ; 10: 569-574. (Pubitemid 39207232)
16. Goodkin DE EDSS reliability. Neurology 1991 ; 41: 332.
17. Kaufman M., Moyer D. and Norton J. The significant change for the Timed 25-foot Walk in the multiple sclerosis functional composite. Mult Scler 2000 ; 6: 286-290.
18. Costelloe L., O'Rourke K., Kearney H., et al. The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical). J Neurol Neurosurg Psychiatry 2007 ; 78: 841-844. 19. Amato MP, Fratiglioni L., Groppi C., Siracusa G. and Amaducci L. Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis. Arch Neurol 1988 ; 45: 746-748. (Pubitemid 47204589)
19. Francis DA, Bain P., Swan AV and Hughes RA An assessment of disability rating scales used in multiple sclerosis. Arch Neurol 1991 ; 48: 299-301.
20. Goodkin DE, Cookfair D., Wende K., et al. Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group. Neurology 1992 ; 42: 859-863.
21. Goodkin DE, Priore RL, Wende KE, et al. Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials. The Multiple Sclerosis Collaborative Research Group (MSCRG). Mult Scler 1998 ; 4: 480-486. (Pubitemid 29042154)
22. Kragt JJ, Nielsen IM, van der Linden FA, Uitdehaag BM and Polman CH How similar are commonly combined criteria for EDSS progression in multiple sclerosis? Mult Scler 2006 ; 12: 782-786. (Pubitemid 46111771)
23. Noseworthy JH, Vandervoort MK, Wong CJ and Ebers GC Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group. Neurology 1990 ; 40: 971-975. (Pubitemid 20201827)
24. Schwid SR, Goodman AD, Apatoff BR, et al. Are quantitative functional measures more sensitive to worsening MS than traditional measures? Neurology 2000 ; 55: 1901-1903. (Pubitemid 32103975)
25. Hobart J. and Cano S. Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods. Health Technol Assess 2009 ; 13 (12). 1-200.
26. O'Connor RJ, Cano SJ, Thompson AJ and Hobart JC Exploring rating scale responsiveness: does the total score reflect the sum of its parts? Neurology 2004 ; 62: 1842-1844. (Pubitemid 38661747)
27. Streiner DL and Norman GR Health measurement scales, a practical guide to their development and use. Oxford: Oxford Medical Publications, 1995.